MedApp - Telehealth Europe Solutions/Service Company
healthcaretechoutlook

MedApp: Broadening the Scope of Digital Medicine

Follow MedApp on :

Krzysztof Mędrala, CEO, MedAppKrzysztof Mędrala, CEO, MedApp
Telemedicine, generally understood as remote consultations alone, fall short in providing patients with optimal care. Despite its broad applications in the wake of Covid-19, telemedicine could not establish itself as a replacement for in-person consultation with a physician. The situation has been particularly challenging for chronically ill patients. After all, conditions such as diabetes, stroke, cancer, and dementia already by far claim more lives than Covid-19. Further, with the world population above the age of 60 expected to rise to 2.1 billion by 2050, the demand for medical services will significantly increase. At the same time, the number of experienced medical personnel is expected to decline, which will, in turn, grow the demand for high-quality medical services in the next 2-3 years and beyond.

Existing digital medicine solutions can only partially address these imbalances, and there continues to be a growing need for better quality care—remote and home-based. That is where MedApp can help. “Our goal is not only to provide better care and monitoring tools for chronically ill patients but also to enable expedited referrals and diagnosis especially for groups of patients without easy access to daily GP services,” says Mr Krzysztof Mędrala, the CEO of MedApp. The company’s digital medicine platform as a service called CarnaLife System is based on the long-term monitoring of the patient’s health and is ideal for earlier detection of abnormalities while providing the widest possible health support, to ultimately allow clinicians to deliver better care.

CarnaLife System combines a telemedicine module and advanced AI-based data analytics algorithms that allow clinicians to diagnose and monitor their patients and conduct consultations at any time and location. The application provides a unique opportunity to combine medical consultations with in-depth diagnostics supported by more than 20 types of CE and additionally FDA-approved medical devices whose outputs can be analyzed 24/7. Such a unique combination of teleconsultation software with a range of remote monitoring capabilities enables long-term, in-depth, value-based healthcare.


Our goal is not only to provide better care and monitoring tools for chronically ill patients but also to enable expedited referrals and diagnosis especially for a group of chronically ill patients without easy access to daily GP services

Further, due to its advanced data analytics and algorithms, CarnaLife System has been certified in Europe as a Class II b diagnostic support medical device. The offering leverages Microsoft Azure cloud to store data securely and enables collaborations with tools like Microsoft Teams.

“Close cooperation with Microsoft guarantees highest level of security and accessibility of the data from any location. Our vision is to scale up the process also outside of Europe, potentially with regional and local partners,” mentions Mr Mędrala.

Being a publically listed technology company, MedApp’s mission is to improve healthcare and provide physician support in treating patients. The company focuses on two areas: telemedicine and imaging diagnostics. The common denominator is to support clinicians enabling them to provide more effective and better quality care. “Our solutions are dedicated for outpatient clinics and hospitals and also for pharmaceutical companies looking for tools that will facilitate their communication with doctors and patients - for example as part of the clinical trials”, concludes Mr Mędrala.

As such, apart from CarnaLife System, the company also offers technology-based solutions such as CarnaLife Holo and HoloComm. CarnaLife Holo is a certified innovative software technology that supports the planning and execution of complex medical procedures. With the help of Microsoft’s HoloLens 2 goggles, clinicians can see in real space a 3D hologram that reflects imaged anatomical area. They can also freely interact with the displayed hologram. CarnaLife Holo is now present in 18 medical facilities worldwide and has been used in over 120 medical procedures thus far. HoloComm is an engaging platform for the remote 3D presentation of products, content, and relevant product data that can be widely used in industry, e.g. during remote audits. This product also uses Microsoft HoloLens 2 goggles.

Being in the industry since 2010, what differentiates MedApp is its expert software engineers, medical experts and marketing personnel who have many years of experience using technology to deliver memorable user experience and inter-connectivity, to bring advanced monitoring and diagnostic solutions. “Our motto is to empower people for better heath,” c Krzysztof Mędrala oncludes Mr Mędrala.

Share this Article:
Top 10 Telehealth Solution Companies in Europe - 2021
MedApp

Company
MedApp

Headquarters
Maopolska, Poland

Management
Krzysztof Mędrala, CEO, MedApp

Description
CarnaLife System combines a telemedicine module and advanced AI-based data analytics algorithms that allow clinicians to diagnose and monitor their patients and conduct consultations at any time and location. The application provides a unique opportunity to combine medical consultations with in-depth diagnostics supported by more than 20 types of CE and additionally FDA-approved medical devices whose outputs can be analyzed24/7. Such a unique combination of teleconsultation software with a range of remote monitoring capabilities enables long-term, in-depth, value-based healthcare. Further, due to its advanced data analytics and algorithms, CarnaLife System has been certified in Europe as a Class II b diagnostic support medical device